首页> 外文期刊>Modern Pathology >Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior
【24h】

Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior

机译:肾髓样癌:横纹肌特征和缺乏INI1表达作为攻击行为的标志

获取原文
       

摘要

Renal medullary carcinoma is a rare, well-recognized highly aggressive tumor of varied histopathology, which occurs in young patients with sickle cell trait or disease. Rhabdoid elements, occasionally seen in high-grade renal tumors including renal medullary carcinoma, possibly represent a pathologic marker of aggressive behavior. INI1 (hSNF5/SMARCB1/BAF47) is a highly conserved factor in the ATP-dependent chromatin-modifying complex. Loss of this factor in mice results in aggressive rhabdoid tumors or lymphomas. In humans, the loss of INI1 expression has been reported in pediatric renal rhabdoid tumors, central nervous system atypical teratoid/rhabdoid tumors and epithelioid sarcomas, a possible primary soft tissue rhabdoid tumor. This study compares five renal medullary carcinomas with 10 high-grade renal cell carcinomas (five with rhabdoid features), two urothelial carcinomas and two pediatric renal rhabdoid tumors. All five renal medullary carcinomas, irrespective of histopathology, showed complete loss of INI1 expression similar to that seen in pediatric renal rhabdoid tumors. In contrast, all renal cell carcinomas or urothelial carcinomas, including those with histological rhabdoid features, expressed INI1. Clinically, all five of the patients with renal medullary carcinoma and the two patients with rhabdoid tumors presented with extra-renal metastases at the time of diagnosis. This study demonstrates that renal medullary carcinoma and renal rhabdoid tumor share a common molecular/genetic alteration, which is closely linked to their aggressive biological behavior. However, the absence of INI1 expression is not necessarily predictive of rhabdoid histopathology but remains associated with aggressive behavior in renal medullary carcinoma.
机译:肾髓样癌是一种罕见的,公认的高度侵袭性的,具有多种组织病理学的肿瘤,发生在具有镰状细胞特征或疾病的年轻患者中。在包括肾髓样癌在内的高度肾脏肿瘤中偶见的横纹肌元素可能代表了侵略行为的病理学标志。 INI1(hSNF5 / SMARCB1 / BAF47)在ATP依赖的染色质修饰复合物中是高度保守的因子。小鼠中该因子的丢失会导致侵袭性横纹肌瘤或淋巴瘤。在人类中,已经报道了小儿肾脏类横纹肌瘤,中枢神经系统非典型类畸形/类胡萝卜瘤和上皮样肉瘤(可能是原发性软组织类横纹肌瘤)中INI1表达的丧失。这项研究比较了五种肾髓样癌与十种高级别肾细胞癌(五种具有横纹肌特征),两种尿路上皮癌和两种小儿肾横纹肌瘤。不论组织病理学如何,所有五种肾髓样癌均显示INI1表达完全丧失,与小儿肾脏横纹肌瘤相似。相反,所有肾细胞癌或尿路上皮癌,包括具有组织学横纹肌样特征的肾癌或尿路上皮癌,均表达INI1。临床上,在诊断时,所有5名肾髓样癌患者和2名横纹肌瘤患者均出现肾外转移。这项研究表明,肾髓样癌和肾横纹肌瘤具有共同的分子/遗传改变,这与它们的侵袭性生物学行为密切相关。但是,缺乏INI1表达不一定预示着横纹肌组织病理学,但仍与肾髓样癌的攻击行为有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号